{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:10:52Z","timestamp":1685560252084},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/inf.0b013e3181db741b","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T00:08:26Z","timestamp":1270598906000},"page":"774-777","source":"Crossref","is-referenced-by-count":4,"title":["ASSOCIATION BETWEEN LIPODYSTROPHY AND LEPTIN IN HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED CHILDREN RECEIVING LOPINAVIR\/RITONAVIR-BASED THERAPY"],"prefix":"10.1097","volume":"29","author":[{"given":"Salvador","family":"Resino","sequence":"first","affiliation":[]},{"given":"Claudia","family":"Palladino","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Lorente","sequence":"additional","affiliation":[]},{"given":"Dariela","family":"Micheloud","sequence":"additional","affiliation":[]},{"given":"Jose","family":"Maria Bell\u00f3n","sequence":"additional","affiliation":[]},{"given":"Beatriz","family":"Larru","sequence":"additional","affiliation":[]},{"given":"Maria Dolores Gurbindo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[]},{"given":"Maria Isabel de","family":"Jos\u00e9","sequence":"additional","affiliation":[]},{"given":"Rosa","family":"Polo","sequence":"additional","affiliation":[]},{"given":"Maria \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-25-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/505213","article-title":"Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.","volume":"43","author":"Resino","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R2-25-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-25-20210202","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.inf.0000257427.19764.ff","article-title":"Impact on weight and height with the use of HAART in HIV-infected children.","volume":"26","author":"Guillen","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R4-25-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000230523.94588.85","article-title":"Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy.","volume":"43","author":"Dzwonek","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-25-20210202","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jac\/dkh431","article-title":"Positive virological outcome after lopinavir\/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.","volume":"54","author":"Resino","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R6-25-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/dkm436","article-title":"Long-term response to highly active antiretroviral therapy with lopinavir\/ritonavir in pre-treated vertically HIV-infected children.","volume":"61","author":"Larru","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R7-25-20210202","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/INF.0b013e31816b4539","article-title":"Double boosted protease inhibitors, saquinavir, and lopinavir\/ritonavir, in nucleoside pretreated children at 48 weeks.","volume":"27","author":"Kosalaraksa","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R8-25-20210202","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","article-title":"Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.","volume":"114","author":"Taylor","year":"2004","journal-title":"Pediatrics"},{"key":"R9-25-20210202","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/507333","article-title":"Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.","volume":"43","author":"Wohl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R10-25-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia.","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"R11-25-20210202","first-page":"45","article-title":"HIV-associated lipodystrophy in children.","volume":"3","author":"Krause","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"key":"R12-25-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity.","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"},{"key":"R13-25-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-6-27","article-title":"The Spanish HIV BioBank: a model of cooperative HIV research.","volume":"6","author":"Garcia-Merino","year":"2009","journal-title":"Retrovirology"},{"key":"R14-25-20210202","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/PL00008400","article-title":"Current evidence for the use of paediatric antiretroviral therapy\u2014a PENTA analysis. Paediatric European Network for the Treatment of AIDS Steering Committee.","volume":"159","author":"Sharland","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R15-25-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.","volume":"25","author":"Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R16-25-20210202","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0b013e3280adc91e","article-title":"The role of adipokines in relation to HIV lipodystrophy.","volume":"21","author":"Sweeney","year":"2007","journal-title":"AIDS"},{"key":"R17-25-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/01.pdr.0000228335.64894.26","article-title":"Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.","volume":"60","author":"Verkauskiene","year":"2006","journal-title":"Pediatr Res"},{"key":"R18-25-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/JPEM.2007.20.1.65","article-title":"Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIV-associated facial lipoatrophy.","volume":"20","author":"Kim","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R19-25-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365510601045062","article-title":"Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy.","volume":"67","author":"Papaevangelou","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"R20-25-20210202","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.inf.0000142170.52155.7f","article-title":"Salvage antiretroviral therapy in HIV-infected children: advantages of lopinavir-ritonavir.","volume":"23","author":"Resino","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R21-25-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00431-006-0193-1","article-title":"Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.","volume":"166","author":"Ene","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R22-25-20210202","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"R23-25-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/135965350601100601","article-title":"Protease inhibitor effects on triglyceride synthesis and adipokine secretion in human omental and subcutaneous adipose tissue.","volume":"11","author":"Cianflone","year":"2006","journal-title":"Antivir Ther"},{"key":"R24-25-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.33549\/physiolres.930301","article-title":"Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels.","volume":"52","author":"Rosicka","year":"2003","journal-title":"Physiol Res"},{"key":"R25-25-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3844\/ajidsp.2006.141.152","article-title":"Leptin and adiponectin in the HIV associated metabolic syndrome: physiologic and therapeutic implications.","volume":"2","author":"Tsiodras","year":"2006","journal-title":"Am J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3181db741b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:30:20Z","timestamp":1685557820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201008000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181db741b","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}